Cancer Chemoprevention & Herbal Antioxidants 89 243–251, 2005. [4] Surh, Y.H.: Cancer chemoprevention with dietary phyto- chemicals. Nature Rev. Cancer, 3, 768–780, 2003. [5] Moon, Y.J., Wang, X., and Morris, M.E.: Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol. in Vitro, 20, 187–210, 2006. [6] Ciolino, H.P., Daschner, P.J., Wang, T.T.Y., and Yeh, G.C.: Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P4501A1 in MCF-7 human breast carcinoma cells. Biochem. Pharmacol., 56, 197–206, 1998. [7] Hayes, J.D. and McMahon, M.: Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett., 174, 103–113, 2001. [8] Chakraborty, S., Roy, M., and Bhattacharya, R.K.: Prevention and repair of DNA damage by selected phytochemicals as measured by single cell gel electrophoresis. J. Envt. Pathol. Toxicol. Oncol., 23, 215–226, 2004. [9] Manson, M.M.: Inhibition of survival signaling by dietary polyphenols and indole-3-carbinol. Eur. J. Cancer, 41, 1842– 1853, 2005. [10] Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S., and Wang, X.: Cytochrome c and dATP- dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell Mol. Life Sci., 91, 479– 489, 1997. [11] Choudhuri, T., Pal, S., Agarwal, M.L., Das, T., and Sa, G.: Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett., 512, 334– 340, 2002. [12] Greenwald, P.: Clinical trials in cancer prevention: current results and perspectives for the future. J. Nutr., 134, 3507S– 3512S, 2004. [13] Deshpande, S.S., Ingle, A.D., and Maru, G.B.: Inhibitory effects of curcumin free aqueous turmeric extract on benzo(a)pyrene induced stomach papilomas in mice. Cancer Lett., 118, 79–85, 1997. [14] Deshpande, S.S., Ingle, A.D., and Maru, G.B.: Chemo- preventive efficacy of curcumin-free aqueous turmeric extract on 7, 12 dimethylbenz(a)anthraceneinduced rat mammary tumorigenesis. Cancer Lett., 123, 35–40, 1998. [15] Thapliyal, R., Dolas, S.S., Pakhale, S.S., and Maru, G.B.: Evaluation of DNA damage in mice topically exposed to total particulate matter from mainstream and sidestream smoke from cigarettes and bidis. Mutagenesis, 19, 413–421, 2004. [16] Thapliyal, R., Deshpande, S.S., and Maru, G.B.: Effect(s) of turmeric on the activities of benzo(a)pyrene induced cyto- chrome P450 isozymes. J. Envt. Pathol. Toxicol. Oncol., 20, 59–63, 2001. [17] Deshpande, S.S. and Maru, G.B.: Effect(s) of curcumin on the formation of benzo(a)pyrene derived DNA adducts. Cancer Lett., 96, 71–80, 1995. [18] Thapliyal, R. and Maru, G.B.: Inhibition of cytochrome P450 isozymes by curcumin(s) in vitro and in vivo. Food Chem. Toxicol., 39, 541–547, 2001. [19] Thapliyal, R., Deshpande, S.S., and Maru, G.B.: Mecha- nism(s) of turmeric-mediated protective effects against Vol. 40, No. 2, 2007 benzo(a)pyrene-derived DNA adducts. Cancer Lett., 175, 79–88, 2002. [20] Krishnan, R. and Maru, G.B.: Isolation and analyses of polymeric polyphenol fractions from black tea. Food Chem., 94, 331–340, 2006. [21] Krishnan, R., Raghunathan, R., and Maru, G.B.: Effect of polymeric black tea polyphenols on benzo(a)pyrene [B(a)P]- induced cytochrome P4501A1 and 1A2 in mice. Xenobiotica, 35, 671–682, 2005. [22] Krishnan, R. and Maru, G.B.: Inhibitory effect(s) of polymeric black tea polyphenol fractions on the formation of [3H]- B(a)P-derived DNA adducts. J. Agric. Food Chem., 52, 4261–4269, 2004. [23] Krishnan, R. and Maru, G.B.: Inhibitory effect(s) of polymeric black tea polyphenols on the formation of B(a)P-derived DNA adducts in mouse skin. J. Envt. Pathol. Toxicol. Oncol., 24, 103–114, 2005. [24] Krishnan, R., Patel, R.R., Ramchandani, A., and Maru, G.B.: Cancer chemoprevention by tea polyphenols, in Medicinal properties of tea, eds. By Banerjee, B. and Chaudhuri, T.C., Oxford and IBH Publishing Co Pvt Ltd, New Delhi, pp. 133– 170, 2005. [25] Crowell, J.: The chemopreventive agent development research program in the Division of Cancer Prevention of the US National Cancer Institute: an overview. Eur. J. Cancer., 41, 1889–1910, 2005. [26] Gerhauser, C., Klimo, K., Heiss, E., Neumann, I., Gamal- Eldeen, A., Knauft, J., Liu, G., Sitthimonchai, S., and Frank, N.: Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat. Res., 523–524, 163–172, 2003. [27] Steele, V., Sharma, S., Mehta, R., Elmore, E., Redpath, L., Rudd, C., Bagheri, D., Sigman, C., and Kelloff, G.: Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals. J. Cell Biochem. Suppl., 26, 29–53, 1996. [28] Saleem, M., Kweon, M.H., Yun, J.M., Adhami, V.M., Khan, N., Syed, D.N., and Mukhtar, H.: A novel dietary triterpene lupeol induces fas-mediated apoptotic death of androgen- sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Cancer Res., 65, 11203–11213, 2005. [29] Li, Y., Che, M., Bhagat, S., Ellis, K.L., Kucuk, O., Doerge, D.R., Abrams, J., Cher, M.L., and Sarkar, F.H.: Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia, 6, 354–363, 2004. [30] Rao, C., Cooma, I., Rodriguez, J., Simi, B., El-Bayoumy, K., and Reddy, B.: Chemoprevention of familial adenomatous polyposis development in the APC(min) mouse model by 1,4- phenylene bis(methylene)selenocyanate. Carcinogenesis, 21, 617–621, 2000. [31] Stoner, G., Casto, B., Ralston, S., Roebuck, B., Pereira, C., and Bailey, G.: Development of multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3- carbinol. Carcinogenesis, 23, 265–272, 2002. [32] Seifried, H.E., Mcdonald, S.S., Anderson, D.E., Greenwald, P., and Milner, J.A.: The antioxidant conundrum in cancer. Cancer Res., 63, 4295–4298, 2003.